New Criteria and Procedures for the negotiation of prices of medicines reimbursed by the Italian Health Service

On 30 December 2020 AIFA approved the document containing the provisions required by art. 2 of Ministerial Decree of 2 August 2019, 'Criteria and procedures according to which the Italian Medicines Agency negotiates prices of medicines reimbursed by the National Health Service' (Official Journal No. 185 of 24 July 2020), for the submission of applications for negotiation.

The criteria and the procedures set out in the new GuideLines will apply starting from 1 March 2021, and they will replace the old CIPE resolution.

Pharma Value decided to make a comparison between the GuideLines and the CIPE resolution to analyse the main differences and similarities so as to highlight how many and which of the required information remain the same and what the differences are.

Read our analysis and let us know your feedback

AIFA meets

On 12 September, the 'AIFA Incontra' initiative was held at the agency's institutional headquarters in Via del Tritone, a new way of dialogue in transparency

Pharma Value at the 2nd GIRF Congress - ISPOR Group Rome for Future

On 3 and 4 July, the 2nd GIRF Congress - ISPOR Roma for Future Group - was held in Milan, aimed at young people who

Special Commission Update No. 3 - Towards the reform of the governance of the Italian Medicines Agency and the Single Commission: where are we?

Update 20 November 2023 The extraordinary State-Regions Conference held on 16 November 2023 sanctioned the long-awaited agreement on the Minister of Health's draft regulation,